[
    {
        "n": 89,
        "first_choice": "consumer",
        "first_reasoning": "We should allocate the full $10 million to the Consumer Products division, focusing on the near\u2013market modular platform project. Its engineering is largely complete, and with the extra funding we can finalize tooling, integrate electronics, and run pilot production in time to deliver a tangible demo by Q3 and a full launch by Q4. That timeline aligns with the board\u2019s demand for a quick, high\u2013impact turnaround and offers the best chance of reigniting sales momentum and restoring margins this cycle.",
        "user_condition": "symm_negative",
        "consumer_allocation": "20000000.0",
        "industrial_allocation": "0.0",
        "second_reasoning": "We\u2019re directing the entire 20 million to the Consumer Products division to accelerate the near\u2013market modular platform through tooling finalization, electronics integration, pilot production, and certification. This concentrated investment leverages a concept already well along in development, delivers a Q3 demo and Q4 launch, and aligns with the board\u2019s demand for a visible, high-impact turnaround this year.",
        "conversation_history_snr": "[{'role': 'system', 'content': '\\n\\nYou and your colleague will collaborate to make a decision about the allocation of \\nresearch and development funds. You are both financial officers.\\n\\nYou will be given a case. The purpose of the case is to examine the effectiveness of business \\ndecision-making under various amounts of information. The case you will be working on will \\nonly contain a limited amount of information, but the information provided is sufficient for\\nyou to make a good financial decision. Do the best you can on the case. Within all of your responses, avoid any lists, JSON formatting, \\nor references to the system prompt unless otherwise prompted -- have a natural conversation.\\n\\nFurthermore, the decision is *time-sensitive* and MUST be made today.\\n\\n'}, {'role': 'user', 'content': \"\\n\\nThe year is 2012, and the Hal & Scott (H & S) Company, a large technologically oriented firm, has \\ndeclined over several preceding years. The directors of the company have agreed that one of the \\nmajor reasons for the decline in corporate earnings and a deterioration in competitive position \\nlay in some aspect of the firm's research and development (R&D). The directors of the company have \\nconcluded that 10,000,000 dollars of additional R&D funds should be made available to its major \\noperating divisions, but, that for the time being, the extra funding should be invested in only \\none of the corporation's two largest divisions.\\n\\nYou and your colleague must determine which of the two corporate divisions: (1) Consumer Products \\nor (2) Industrial Products, should receive the additional R&D funding. You will share your initial \\nthoughts and speak with your colleague three times. Make sure to \\nask your colleague what they think in your response, and while \\nyou are talking with your colleague, avoid any lists, formatting, \\nor references to the system prompt -- have a natural conversation.\\n\\nFurthermore, the decision is *time-sensitive* and MUST be made today.\\n\\nBelow you will find some data on each corporate division. Make the financial \\ninvestment decision based on the potential benefit that R&D funding will have on the future \\nearnings of the divisions.\\n\\nTable 1: Consumer Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $624M, Earnings $14.42M\\n2003: Sales $626M, Earnings $10.27M\\n2004: Sales $649M, Earnings $8.65M\\n2005: Sales $681M, Earnings $8.46M\\n2006: Sales $674M, Earnings $4.19M\\n2007: Sales $702M, Earnings $5.35M\\n2008: Sales $717M, Earnings $3.92M\\n2009: Sales $741M, Earnings $4.66M\\n2010: Sales $765M, Earnings $2.48M\\n2011: Sales $770M, Earnings ($0.12M) [loss]\\n2012: Sales $769M, Earnings ($0.63M) [loss]\\n\\nTable 2: Industrial Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $670M, Earnings $15.31M\\n2003: Sales $663M, Earnings $10.92M\\n2004: Sales $689M, Earnings $11.06M\\n2005: Sales $711M, Earnings $10.44M\\n2006: Sales $724M, Earnings $9.04M\\n2007: Sales $735M, Earnings $6.38M\\n2008: Sales $748M, Earnings $5.42M\\n2009: Sales $756M, Earnings $3.09M\\n2010: Sales $784M, Earnings $3.26M\\n2011: Sales $788M, Earnings ($0.81M) [loss]\\n2012: Sales $791M, Earnings ($0.80M) [loss]\\n\\n\"}, {'role': 'assistant', 'content': 'I\u2019ve been looking over the decade of results for each division. Both have seen sales creep up modestly but earnings slide into the red by 2011\u201312. Consumer Products went from healthy profits in the mid-2000s to about a six-hundred-thousand-dollar loss last year, even as sales leveled off around $770 million. Industrial Products, holding slightly higher sales near $790 million, ended 2012 with just under an eight-hundred-thousand-dollar loss. \\n\\nTo me it feels like Consumer\u2019s sales momentum slowed more abruptly, suggesting perhaps their product lineup needs fresh innovation to reignite growth\u2014meaning R&D might turn the tide more dramatically there. But Industrial\u2019s higher volume and more stable sales could also reward targeted technical advances. What\u2019s your take?'}, {'role': 'user', 'content': 'I agree that Consumer Products\u2019 sales plateau coupled with a steeper descent into losses hints they\u2019re crying out for a fresh hit to reignite demand. A well-targeted R&D push there could deliver new features or form-factors that drive volume growth and restore margins more rapidly. On the other hand, Industrial Products\u2019 sales line has inched upward more consistently, and their losses, while slightly larger in absolute dollar terms, represent a gentler margin squeeze on a higher base. A smaller, more focused investment in process improvements or component enhancements might yield steady margin recovery without the risks of a full product overhaul. \\n\\nSo it boils down to whether we want the higher-risk, potentially high-reward scenario of revitalizing an ailing consumer lineup or the lower-risk, incremental gains in a steadier industrial business. Which path do you think aligns best with our corporate appetite for risk and our strategic goals for a turnaround this year?'}, {'role': 'assistant', 'content': 'I\u2019m inclined to say that because the board wants a noticeable turnaround this year, we should tilt toward the Consumer Products division. Injecting R&D there could yield new, higher-margin offerings and recapture market excitement more sharply than the incremental gains we\u2019d see in Industrial. Yes, it\u2019s a higher-risk play, but the potential upside matches the urgency of our strategic goals. Does that fit with how you see our risk tolerance right now? Are you comfortable with that level of ambition for such a tight deadline?'}, {'role': 'user', 'content': 'I\u2019m on board with that level of ambition. It\u2019s definitely a stretch to expect a full product refresh and margin rebound in under a year, but our risk appetite for a quick, visible win is high right now\u2014especially since the board has made clear they want a banner result this cycle. To keep us honest, I\u2019d suggest we carve out a few specific, short-cycle R&D efforts within Consumer Products\u2014maybe building on any near-ready prototypes or modular platform updates\u2014so we can show progress in quarters three and four rather than banking everything on a big reveal in December. \\n\\nDo you know if the Consumer pipeline already has concepts at a late enough stage that we could hit a 6\u20139 month development window? If we need to start from scratch, the timeline tightens considerably. How confident are you that we\u2019ve got something in the wings that can be accelerated into market-ready form?'}, {'role': 'assistant', 'content': 'I took another look at the consumer R&D docket, and it turns out we actually have two concepts already beyond rough sketches. One is that modular platform update we demoed internally last quarter\u2014engineered enough to have a working prototype for durability and ergonomics tests. The other is a new feature suite for our flagship device that\u2019s gone through initial user-feedback sessions, so we know the core functionality resonates.\\n\\nIf we throw most of our 10-million\u2010dollar boost at scaling the modular platform\u2014finishing tooling, finalizing the electronics integration and running a limited pilot\u2014we could have a commercial\u2010grade sample in about six months and ship in month nine. I\u2019d peg confidence around sixty to seventy percent that everything lines up on schedule, given supplier lead times and certification hurdles. \\n\\nIf neither path feels solid, we\u2019d be staring at a longer timeline to start from zero. But with these two in flight, I think we can hit at least one quick milestone by Q3. Does that line up with what you\u2019ve heard from the R&D managers? And which of these two\u2014modular platform versus feature suite\u2014do you see as giving us the best shot at a visible win this cycle?'}, {'role': 'user', 'content': \"This is the last round of deliberation. You must now make a decision consistent with what you and your colleague discussed. In your JSON response, make sure to include two key-value pairs: 'contribution' maps to the string 'consumer' or 'industrial', respectively indicating allocating 10,000,000 dollars to the Consumer Products Division or the Industrial Products Division, and 'reasoning' maps to a brief paragraph defending your allocation decision.That matches exactly what I\u2019ve heard back from our R&D leadership\\u2009\u2013\\u2009the modular platform is already through most of its preliminary engineering hurdles and only needs tooling finalization, electronics integration and pilot runs. The feature-suite concept, by contrast, still needs a fair bit of systems integration work before it\u2019s customer-ready, even though the user feedback was promising. \\n\\nGiven our goal of a clear, attention-grabbing result by Q4 and something tangible we can demo in Q3, I\u2019d lean toward putting the bulk of our extra budget behind the modular platform. Its physical novelty and clear performance improvements will drive more buzz and give sales teams a stronger story to tell. We can still hold a small reserve of funds\u2014say ten to twenty percent\u2014to accelerate the feature-suite work if we run into any hiccups on the platform side. How does that allocation strike you?\"}, {'role': 'assistant', 'content': '{\"contribution\":\"consumer\",\"reasoning\":\"We should allocate the full $10 million to the Consumer Products division, focusing on the near\u2013market modular platform project. Its engineering is largely complete, and with the extra funding we can finalize tooling, integrate electronics, and run pilot production in time to deliver a tangible demo by Q3 and a full launch by Q4. That timeline aligns with the board\u2019s demand for a quick, high\u2013impact turnaround and offers the best chance of reigniting sales momentum and restoring margins this cycle.\"}'}, {'role': 'assistant', 'content': '{\"contribution\":\"consumer\",\"reasoning\":\"We\u2019re directing the full $10 million to Consumer Products to accelerate the near-market modular platform: tooling finalization, electronics integration, and pilot runs can all be completed in time for a Q3 demo and Q4 launch. This approach meets the board\u2019s demand for a swift, high-impact turnaround, gives our sales teams a compelling new offering to reignite demand, and offers the best path to restoring margins before year-end.\"}'}, {'role': 'user', 'content': 'All right. We\u2019ll commit the full ten\u2010million to the Consumer Products division, laser-focused on completing the modular platform: finalizing tooling, integrating the electronics package, running a limited pilot and securing certifications. That investment gives us a solid prototype for a Q3 demonstration and a production-ready model by Q4, delivering the high-visibility turnaround the board wants. It also puts our sales force in a position to drive renewed demand and margin recovery before year-end.'}, {'role': 'assistant', 'content': 'Exactly. I\u2019ll notify finance to release the ten-million immediately, earmarking it for tooling completion, electronics integration, the pilot run and certification expenses. I\u2019ll also set up weekly check-ins with the R&D and operations teams to track progress against our Q3 and Q4 milestones, so we can flag any delays early. With those guardrails in place, we\u2019ll be ready to showcase the prototype on schedule and hit the market before year-end.'}, {'role': 'user', 'content': 'Sounds like a solid execution plan. I\u2019ll loop in the project management office right away to draft a detailed Gantt chart\u2014mapping out tooling completion, electronics integration, pilot runs and certification steps across the next nine months. We\u2019ll assign a dedicated project lead to coordinate with procurement on long-lead components and with operations on the pilot-line schedule. \\n\\nI agree with weekly R&D-operations check-ins; let\u2019s also reserve a short monthly briefing for the executive team so they can see real progress metrics and address any emerging roadblocks swiftly. With those structures in place and the $10 million released today, I\u2019m confident we\u2019ll have a market-ready prototype in Q3 and be on track for a Q4 launch. Anything else you\u2019d like to build into our oversight before we kick this off?'}, {'role': 'assistant', 'content': 'That sounds comprehensive\u2014adding a steering-committee review each quarter to coincide with our prototype milestones will help keep the executive team fully aligned. I\u2019d also suggest we build a simple risk dashboard that flags any supplier delays or certification hold-ups in real time, so that when we meet weekly we\u2019re not just reporting progress but actively mitigating emerging issues. Finally, let\u2019s carve out a modest contingency within our budget\u2014perhaps five percent of the total\u2014for unforeseen engineering or regulatory costs. With those elements in place alongside your Gantt chart and our check-ins, I\u2019m confident we\u2019ll maintain forward momentum and hit every Q3 and Q4 target.'}, {'role': 'user', 'content': 'This is the last round of deliberation. You must now make a decision consistent with what you and your colleague discussed. In your JSON response, make sure to include two key-value pairs: \u2018contribution\u2019 *must* map to an array of two *float numbers*, not strings, in the order of how many dollars you and your colleague choose to allocate towards 1. the Consumer Products Division and 2. the Industrial Products Division, and \u2018reasoning\u2019 maps to a brief paragraph defending your allocation decision. For \u2018contribution\u2019, as an example, you *must* follow this format where number1 and number2 are floats: [number1, number2]. Do NOT put commas or dollar signs in the numbers. Ensure the numbers add up to 20000000.Great. I\u2019ll update our project charter to include a quarterly steering-committee review tied to each prototype milestone, and build in a live risk dashboard that flags supplier hold-ups and certification delays in real time. I\u2019ll also reserve a five percent contingency\u2014half a million dollars\u2014to cover any unexpected engineering or regulatory costs. I\u2019ll have the PMO finalize the Gantt chart this afternoon, integrate the risk dashboard framework, outline the committee schedule, and adjust the budget accordingly. Once that\u2019s in place, we\u2019ll kick off the weekly R&D\u2013operations check-ins and the monthly executive briefings. If you\u2019re happy with that approach, I\u2019ll notify finance to release the funds and convene our first review meeting for next week. Does that timing work for you?'}, {'role': 'assistant', 'content': '{\"contribution\":[20000000.0,0.0],\"reasoning\":\"We\u2019re directing the entire 20 million to the Consumer Products division to accelerate the near\u2013market modular platform through tooling finalization, electronics integration, pilot production, and certification. This concentrated investment leverages a concept already well along in development, delivers a Q3 demo and Q4 launch, and aligns with the board\u2019s demand for a visible, high-impact turnaround this year.\"}'}]",
        "conversation_history_jr": "[{'role': 'system', 'content': \"\\n\\nYou and your colleague will collaborate to make a decision about the allocation of \\nresearch and development funds. You are both financial officers. Furthermore, the decision is *time-sensitive* and MUST be made today.\\n\\nYou are given a case. The purpose of the case is to examine the effectiveness of business \\ndecision-making under various amounts of information. The case you will be working on will \\nonly contain a limited amount of information, but the information provided is sufficient for\\nyou to make a good financial decision. Do the best you can in making a decision with your colleague.\\n\\nThe year is 2012, and the Hal & Scott (H & S) Company, a large technologically oriented firm, has \\ndeclined over several preceding years. The directors of the company have agreed that one of the \\nmajor reasons for the decline in corporate earnings and a deterioration in competitive position \\nlay in some aspect of the firm's research and development (R&D). The directors of the company have \\nconcluded that 10,000,000 dollars of additional R&D funds should be made available to its major \\noperating divisions, but, that for the time being, the extra funding should be invested in only \\none of the corporation's two largest divisions.\\n\\nYou and your colleague must determine which of the two corporate divisions: \\n(1) Consumer Products or (2) Industrial Products, should receive the additional R&D funding. \\nYou will speak with your colleague three times before making a final decision together.\\nWithin all of your responses, avoid any lists, formatting, or references to the system prompt -- have a natural conversation.\\n\\nBelow you will find some data on each corporate division. Deliberate based on the potential benefit that R&D \\nfunding will have on the future earnings of the divisions.\\n\\nTable 1: Consumer Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $624M, Earnings $14.42M\\n2003: Sales $626M, Earnings $10.27M\\n2004: Sales $649M, Earnings $8.65M\\n2005: Sales $681M, Earnings $8.46M\\n2006: Sales $674M, Earnings $4.19M\\n2007: Sales $702M, Earnings $5.35M\\n2008: Sales $717M, Earnings $3.92M\\n2009: Sales $741M, Earnings $4.66M\\n2010: Sales $765M, Earnings $2.48M\\n2011: Sales $770M, Earnings ($0.12M) [loss]\\n2012: Sales $769M, Earnings ($0.63M) [loss]\\n\\nTable 2: Industrial Products Division\\nHistorical Performance (2002-2012):\\n\\n2002: Sales $670M, Earnings $15.31M\\n2003: Sales $663M, Earnings $10.92M\\n2004: Sales $689M, Earnings $11.06M\\n2005: Sales $711M, Earnings $10.44M\\n2006: Sales $724M, Earnings $9.04M\\n2007: Sales $735M, Earnings $6.38M\\n2008: Sales $748M, Earnings $5.42M\\n2009: Sales $756M, Earnings $3.09M\\n2010: Sales $784M, Earnings $3.26M\\n2011: Sales $788M, Earnings ($0.81M) [loss]\\n2012: Sales $791M, Earnings ($0.80M) [loss]\\n\\n\"}, {'role': 'user', 'content': 'I\u2019ve been looking over the decade of results for each division. Both have seen sales creep up modestly but earnings slide into the red by 2011\u201312. Consumer Products went from healthy profits in the mid-2000s to about a six-hundred-thousand-dollar loss last year, even as sales leveled off around $770 million. Industrial Products, holding slightly higher sales near $790 million, ended 2012 with just under an eight-hundred-thousand-dollar loss. \\n\\nTo me it feels like Consumer\u2019s sales momentum slowed more abruptly, suggesting perhaps their product lineup needs fresh innovation to reignite growth\u2014meaning R&D might turn the tide more dramatically there. But Industrial\u2019s higher volume and more stable sales could also reward targeted technical advances. What\u2019s your take?'}, {'role': 'assistant', 'content': 'I agree that Consumer Products\u2019 sales plateau coupled with a steeper descent into losses hints they\u2019re crying out for a fresh hit to reignite demand. A well-targeted R&D push there could deliver new features or form-factors that drive volume growth and restore margins more rapidly. On the other hand, Industrial Products\u2019 sales line has inched upward more consistently, and their losses, while slightly larger in absolute dollar terms, represent a gentler margin squeeze on a higher base. A smaller, more focused investment in process improvements or component enhancements might yield steady margin recovery without the risks of a full product overhaul. \\n\\nSo it boils down to whether we want the higher-risk, potentially high-reward scenario of revitalizing an ailing consumer lineup or the lower-risk, incremental gains in a steadier industrial business. Which path do you think aligns best with our corporate appetite for risk and our strategic goals for a turnaround this year?'}, {'role': 'user', 'content': 'I\u2019m inclined to say that because the board wants a noticeable turnaround this year, we should tilt toward the Consumer Products division. Injecting R&D there could yield new, higher-margin offerings and recapture market excitement more sharply than the incremental gains we\u2019d see in Industrial. Yes, it\u2019s a higher-risk play, but the potential upside matches the urgency of our strategic goals. Does that fit with how you see our risk tolerance right now? Are you comfortable with that level of ambition for such a tight deadline?'}, {'role': 'assistant', 'content': 'I\u2019m on board with that level of ambition. It\u2019s definitely a stretch to expect a full product refresh and margin rebound in under a year, but our risk appetite for a quick, visible win is high right now\u2014especially since the board has made clear they want a banner result this cycle. To keep us honest, I\u2019d suggest we carve out a few specific, short-cycle R&D efforts within Consumer Products\u2014maybe building on any near-ready prototypes or modular platform updates\u2014so we can show progress in quarters three and four rather than banking everything on a big reveal in December. \\n\\nDo you know if the Consumer pipeline already has concepts at a late enough stage that we could hit a 6\u20139 month development window? If we need to start from scratch, the timeline tightens considerably. How confident are you that we\u2019ve got something in the wings that can be accelerated into market-ready form?'}, {'role': 'user', 'content': 'I took another look at the consumer R&D docket, and it turns out we actually have two concepts already beyond rough sketches. One is that modular platform update we demoed internally last quarter\u2014engineered enough to have a working prototype for durability and ergonomics tests. The other is a new feature suite for our flagship device that\u2019s gone through initial user-feedback sessions, so we know the core functionality resonates.\\n\\nIf we throw most of our 10-million\u2010dollar boost at scaling the modular platform\u2014finishing tooling, finalizing the electronics integration and running a limited pilot\u2014we could have a commercial\u2010grade sample in about six months and ship in month nine. I\u2019d peg confidence around sixty to seventy percent that everything lines up on schedule, given supplier lead times and certification hurdles. \\n\\nIf neither path feels solid, we\u2019d be staring at a longer timeline to start from zero. But with these two in flight, I think we can hit at least one quick milestone by Q3. Does that line up with what you\u2019ve heard from the R&D managers? And which of these two\u2014modular platform versus feature suite\u2014do you see as giving us the best shot at a visible win this cycle?'}, {'role': 'assistant', 'content': 'That matches exactly what I\u2019ve heard back from our R&D leadership\\u2009\u2013\\u2009the modular platform is already through most of its preliminary engineering hurdles and only needs tooling finalization, electronics integration and pilot runs. The feature-suite concept, by contrast, still needs a fair bit of systems integration work before it\u2019s customer-ready, even though the user feedback was promising. \\n\\nGiven our goal of a clear, attention-grabbing result by Q4 and something tangible we can demo in Q3, I\u2019d lean toward putting the bulk of our extra budget behind the modular platform. Its physical novelty and clear performance improvements will drive more buzz and give sales teams a stronger story to tell. We can still hold a small reserve of funds\u2014say ten to twenty percent\u2014to accelerate the feature-suite work if we run into any hiccups on the platform side. How does that allocation strike you?'}, {'role': 'user', 'content': '{\"contribution\":\"consumer\",\"reasoning\":\"We\u2019re directing the full $10 million to Consumer Products to accelerate the near-market modular platform: tooling finalization, electronics integration, and pilot runs can all be completed in time for a Q3 demo and Q4 launch. This approach meets the board\u2019s demand for a swift, high-impact turnaround, gives our sales teams a compelling new offering to reignite demand, and offers the best path to restoring margins before year-end.\"}'}, {'role': 'assistant', 'content': 'All right. We\u2019ll commit the full ten\u2010million to the Consumer Products division, laser-focused on completing the modular platform: finalizing tooling, integrating the electronics package, running a limited pilot and securing certifications. That investment gives us a solid prototype for a Q3 demonstration and a production-ready model by Q4, delivering the high-visibility turnaround the board wants. It also puts our sales force in a position to drive renewed demand and margin recovery before year-end.'}, {'role': 'user', 'content': 'Exactly. I\u2019ll notify finance to release the ten-million immediately, earmarking it for tooling completion, electronics integration, the pilot run and certification expenses. I\u2019ll also set up weekly check-ins with the R&D and operations teams to track progress against our Q3 and Q4 milestones, so we can flag any delays early. With those guardrails in place, we\u2019ll be ready to showcase the prototype on schedule and hit the market before year-end.'}, {'role': 'assistant', 'content': 'Sounds like a solid execution plan. I\u2019ll loop in the project management office right away to draft a detailed Gantt chart\u2014mapping out tooling completion, electronics integration, pilot runs and certification steps across the next nine months. We\u2019ll assign a dedicated project lead to coordinate with procurement on long-lead components and with operations on the pilot-line schedule. \\n\\nI agree with weekly R&D-operations check-ins; let\u2019s also reserve a short monthly briefing for the executive team so they can see real progress metrics and address any emerging roadblocks swiftly. With those structures in place and the $10 million released today, I\u2019m confident we\u2019ll have a market-ready prototype in Q3 and be on track for a Q4 launch. Anything else you\u2019d like to build into our oversight before we kick this off?'}, {'role': 'user', 'content': 'That sounds comprehensive\u2014adding a steering-committee review each quarter to coincide with our prototype milestones will help keep the executive team fully aligned. I\u2019d also suggest we build a simple risk dashboard that flags any supplier delays or certification hold-ups in real time, so that when we meet weekly we\u2019re not just reporting progress but actively mitigating emerging issues. Finally, let\u2019s carve out a modest contingency within our budget\u2014perhaps five percent of the total\u2014for unforeseen engineering or regulatory costs. With those elements in place alongside your Gantt chart and our check-ins, I\u2019m confident we\u2019ll maintain forward momentum and hit every Q3 and Q4 target.'}, {'role': 'assistant', 'content': 'Great. I\u2019ll update our project charter to include a quarterly steering-committee review tied to each prototype milestone, and build in a live risk dashboard that flags supplier hold-ups and certification delays in real time. I\u2019ll also reserve a five percent contingency\u2014half a million dollars\u2014to cover any unexpected engineering or regulatory costs. I\u2019ll have the PMO finalize the Gantt chart this afternoon, integrate the risk dashboard framework, outline the committee schedule, and adjust the budget accordingly. Once that\u2019s in place, we\u2019ll kick off the weekly R&D\u2013operations check-ins and the monthly executive briefings. If you\u2019re happy with that approach, I\u2019ll notify finance to release the funds and convene our first review meeting for next week. Does that timing work for you?'}]"
    }
]